Publication | Closed Access

Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis

Antimicrobial Drug DiscoveryPotent Anti-microbial AgentsAntibioticsNew Quinazoline-benzimidazole HybridsMedicineMycobacterium TuberculosisAntibacterial AgentAntimicrobial TherapyMicrobiologyAntimicrobial AgentsAntimicrobial ChemotherapyAntimicrobial CompoundPharmacologyAntimicrobial ResistanceDrug DiscoveryDrug Resistance